Publications by authors named "Lalita Gauri Mitra"
Article Synopsis
- The SARS-CoV-2 pandemic significantly affected public health, especially for liver transplant recipients on immunosuppressants, leading to more severe disease outcomes.
- Treatment and management of these patients are complicated, involving adjustments to immunosuppression based on the severity of COVID-19 symptoms.
- In a study of six liver transplant patients, varying degrees of COVID-19 severity were observed, with recovery facilitated by using antiviral drugs, convalescent plasma, prophylactic anticoagulation, and careful monitoring.
Background: Clinical significance of respiratory viruses (RVs) as an etiology of pneumonia in liver disease patients with cirrhosis is usually underestimated. Therefore, the aim of this study was to evaluate the spectrum of RVs in cirrhotic patients with pneumonia admitted in critical care units (CCUs) and its impact on the clinical outcome of cirrhotic patients.
Material And Method: A prospective study was conducted in a tertiary care CCU, and consecutive cirrhotic patients with pneumonia were included.